文献速递消化内镜消化道肿瘤与早癌

40-49岁与50-59岁患者结肠镜检查后异时性进展期肿瘤风险比较

The Risk of Metachronous Advanced Neoplasia After Colonoscopy in Patients Aged 40-49 Years Compared With That in Patients Aged 50-59 Years.
PubMed 文献 · Am J Gastroenterol · 2022-08-12

这项回顾性队列研究纳入2010-2013年首次结肠镜检查的40-59岁Kaiser Permanente北加州成员共11,374例,随访至2018年12月31日。与50-59岁组相比,40-49岁组在基线无腺瘤时异时性进展期肿瘤风险较低(HR 0.58;95%CI 0.39-0.83),在非进展期腺瘤或进展期腺瘤时风险无差异。作者认为现行监测结肠镜指南可能适用于40-49岁接受结肠镜检查的患者。

要点

  • 40-49岁组基线无腺瘤者异时性进展期肿瘤风险低于50-59岁组(HR 0.58;95%CI 0.39-0.83)。
  • 基线非进展期腺瘤者两组风险无差异(HR 0.84;95%CI 0.54-1.24)。
  • 基线进展期腺瘤者两组风险无差异(HR 0.83;95%CI 0.51-1.31)。

核心结论

  • 与50-59岁患者相比,40-49岁患者在基线结肠镜未检出腺瘤时异时性进展期肿瘤风险可能较低,检出非进展期腺瘤或进展期腺瘤时风险相似。
  • 这些数据提示现行监测结肠镜指南可能适用于接受结肠镜检查的40-49岁患者。

研究设计与样本

  • 回顾性队列研究,纳入2010-2013年在Kaiser Permanente北加州接受首次(基线)结肠镜检查的40-59岁成员。
  • 共纳入11,374例患者,其中40-49岁组2,396例,50-59岁组8,978例。
  • 随访至死亡、退出保险、监测结肠镜检出进展期肿瘤或2018年12月31日。
  • 采用Cox回归估计进展期肿瘤发生风险,并校正混杂因素。

主要发现

  • 基线无腺瘤者监测结肠镜检出进展期肿瘤:40-49岁组2.2% vs 50-59岁组4.4%(P=0.0003)。
  • 基线非进展期腺瘤者监测结肠镜检出进展期肿瘤:40-49岁组4.6% vs 50-59岁组7.0%(P=0.03)。
  • 基线进展期腺瘤者监测结肠镜检出进展期肿瘤:40-49岁组7.9% vs 50-59岁组11.7%(P=0.06)。
  • 与50-59岁组相比,40-49岁组基线无腺瘤时异时性进展期肿瘤风险较低(HR 0.58;95%CI 0.39-0.83)。
  • 与50-59岁组相比,40-49岁组基线非进展期腺瘤(HR 0.84;95%CI 0.54-1.24)或进展期腺瘤(HR 0.83;95%CI 0.51-1.31)时异时性进展期肿瘤风险无差异。

临床怎么用

  • 作者认为,这些数据提示现行监测结肠镜指南可能适用于接受结肠镜检查的40-49岁患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study investigated the risk of metachronous advanced neoplasia (AN) after colonoscopy in individuals aged 40-49 years compared with that in individuals aged 50-59 years. METHODS: A retrospective cohort study was performed among Kaiser Permanente Northern California members aged 40-59 years who had their first (index) colonoscopy in 2010-2013. Participants were followed up until death, disenrollment, AN on surveillance colonoscopy, or December 31, 2018. The risk for the development of AN was estimated using the Cox regression, adjusted for confounders. RESULTS: The study included 11,374 patients (2,396 aged 40-49 years and 8,978 aged 50-59 years). When comparing the 40-49 years group with the 50-59 years group, AN was detected in 2.2% vs 4.4% ( P = 0.0003) on surveillance colonoscopy after index colonoscopy finding of no adenoma, in 4.6% vs 7.0% ( P = 0.03) after a finding of nonadvanced adenoma (NAA), and in 7.9% vs 11.7% ( P = 0.06) after a finding of advanced adenoma (AA), respectively. Compared with the 50-59 years group, the 40-49 years group had a lower risk of metachronous AN when no adenoma was detected on index colonoscopy (hazard ratio [HR] 0.58; 95% confidence interval [CI] 0.39-0.83) and no difference when NAA (HR 0.84; 95% CI 0.54-1.24) or AA (HR 0.83; 95% CI 0.51-1.31) was detected. DISCUSSION: Compared with patients aged 50-59 years, patients aged 40-49 years may have a lower risk of developing metachronous AN when no adenoma is detected on index colonoscopy and a similar risk when NAA or AA is detected. These data suggest current surveillance colonoscopy guidelines may be applicable to patients aged 40-49 years who undergo colonoscopy.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ma G, Anderson M, Liu L, et al. The Risk of Metachronous Advanced Neoplasia After Colonoscopy in Patients Aged 40-49 Years Compared With That in Patients Aged 50-59 Years. Am J Gastroenterol. 2022. PMID: 35971223. doi:10.14309/ajg.0000000000001946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。